Evaluation of a new rapid COVID-19 diagnostic test

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-198

Grant search

Key facts

  • Disease

  • Funder

    UK Research and Innovation (UKRI)
  • Principle Investigator

  • Research Location

    United Kingdom, Europe
  • Lead Research Institution

    MRC Cancer Unit at the University of Cambridge
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory


  • Special Interest Tags


  • Study Subject


  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment


  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable


A University of Cambridge spinout company, Diagnostics for the Real World, has developed a rapid and accurate point-of-care system (SAMBA II) for the diagnosis of infection with SARS-CoV-2. The COVIDx clinical study is now underway to evaluate the SAMBA II machines, which are able to deliver a diagnosis in less than 90 minutes.